Literature DB >> 12198625

Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections.

James R Johnson1, Thomas A Russo.   

Abstract

Escherichia coli isolates from 3 consecutively encountered patients with serious, invasive, non-urinary tract extraintestinal infections (pneumonia, deep surgical wound infection, and vertebral osteomyelitis with associated epidural/psoas/iliacus abscesses) were characterized, using molecular methods, as to extended virulence genotype and phylogenetic background. All 3 isolates exhibited virulence genotypes and genomic profiles characteristic of specific familiar virulent clones of extraintestinal pathogenic E. coli (ExPEC), which traditionally have been regarded primarily as uropathogenic or as associated with meningitis. These included E. coli O1/O2:K1:H7, E. coli O18:K1:H7, and a recently described E. coli O11/O17/O77:K52:H18 clonal group (clonal group A). These findings demonstrate the extraintestinal pathogenic versatility of ExPEC clones, which supports the use of an inclusive designation for such strains and suggests the possibility of cross-syndrome protective interventions. They also provide novel evidence that multidrug-resistant epidemic clonal group A can cause extraintestinal infections other than uncomplicated urinary tract infections and can cause them in hosts other than young women.

Entities:  

Mesh:

Year:  2002        PMID: 12198625     DOI: 10.1086/342490

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  The unfolding of the P pili quaternary structure by stretching is reversible, not plastic.

Authors:  Erik Fällman; Staffan Schedin; Jana Jass; Bernt-Eric Uhlin; Ove Axner
Journal:  EMBO Rep       Date:  2005-01       Impact factor: 8.807

2.  A sticky chain model of the elongation and unfolding of Escherichia coli P pili under stress.

Authors:  Magnus Andersson; Erik Fällman; Bernt Eric Uhlin; Ove Axner
Journal:  Biophys J       Date:  2005-12-16       Impact factor: 4.033

3.  Effects of ibeA deletion on virulence and biofilm formation of avian pathogenic Escherichia coli.

Authors:  Shaohui Wang; Chunling Niu; Zhenyu Shi; Yongjie Xia; Muhammad Yaqoob; Jianjun Dai; Chengping Lu
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Modeling of the elongation and retraction of Escherichia coli P pili under strain by Monte Carlo simulations.

Authors:  Oscar Björnham; Ove Axner; Magnus Andersson
Journal:  Eur Biophys J       Date:  2007-10-10       Impact factor: 1.733

Review 5.  Targeting iron assimilation to develop new antibacterials.

Authors:  Timothy L Foley; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2012-07-19       Impact factor: 6.098

Review 6.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

7.  Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Authors:  James R Johnson; Abby Gajewski; Alan J Lesse; Thomas A Russo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Changing epidemiology of serious bacterial infections in febrile infants without localizing signs.

Authors:  Kevin Watt; Erica Waddle; Ravi Jhaveri
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

9.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

10.  Signature-tagged mutagenesis in a chicken infection model leads to the identification of a novel avian pathogenic Escherichia coli fimbrial adhesin.

Authors:  Esther-Maria Antão; Christa Ewers; Doreen Gürlebeck; Rudolf Preisinger; Timo Homeier; Ganwu Li; Lothar H Wieler
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.